Security key
68403P203
ORAMED PHARMACEUTICALS INC. - Common Stock (ORMP)
CUSIP: 68403P203
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 3,938,125
- Total 13F value
- $25,517,588
- Share change
- -2,654,394
- Put/Call ratio
- 66%
- SEC-reported price per share
- $6.48
- Number of holders
- 66
- Value change
- -$15,544,475
- Number of buys
- 26
- Number of sells
- 38
- Shares outstanding
- 40,467,431
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
66
Top holders
10
ORMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2022
Previous quarter: Q2 2022
ORAMED PHARMACEUTICALS INC. SEC filings
ORAMED PHARMACEUTICALS INC. company facts
ORAMED PHARMACEUTICALS INC. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 68403P203
Recent filing periods:
Ownership snapshot
Top reported holders of ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 1.7%
Showing 1-6 of 15 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 1.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
1.7%
TWO SIGMA ADVISERS, LP
1.7%
CITADEL ADVISORS LLC
1.6%
TWO SIGMA INVESTMENTS, LP
1.6%
MILLENNIUM MANAGEMENT LLC
1.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
1.7%
|
$3,145,000
686,668 shares
|
— | 30 Jun 2022 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
1.7%
|
$3,123,000
681,800 shares
|
— | 30 Jun 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.6%
|
$2,972,000
648,833 shares
|
— | 30 Jun 2022 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
1.6%
|
$2,929,000
639,557 shares
|
— | 30 Jun 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.4%
|
$2,658,000
580,383 shares
|
— | 30 Jun 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.89%
|
$1,647,000
359,697 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
66
Shares
3,938,125
Rows available
66
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
81
Q3 2022 holders
66
Holder diff
-15
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend